Institutional investors purchased a net $200.00 shares of ENZ during the quarter ended January 2017, and now own 62.34% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EVERMORE GLOBAL ADVISORS LLC Bought 3.3 Million shares of Enzo Biochem Inc